Results 31 to 40 of about 202,126 (199)

Effect of chronic pretreatment with beta-blockers on no-reflow phenomenon in diabetic patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention

The Egyptian Heart Journal, 2017
Background: No-reflow is an important factor as it predicts a poor outcome in patients undergoing primary angioplasty. In comparison with patients attaining TIMI 3 flow, patients with no-reflow have an increased incidence of ventricular arrhythmias ...
Ali Mohammed Kareem Al-Jabari, Ahmed Shawky Elserafy, Hossamaldin Zaki Alsayed Abuemara   +2 more
doaj   +1 more source

Association of Total Ischemia Time with No-Reflow Phenomenon in Patients Presenting with STElevation Myocardial Infarction, Undergoing Primary Percutaneous Coronary Intervention

Pakistan Armed Forces Medical Journal, 2023
Objective: To find out the association of total ischemic time with no-reflow phenomenon, in terms of Thrombolysis in Myocardial Infarction (TIMI) flow grade, in patients presenting with ST-Elevation Myocardial Infarction and undergoing Primary ...
Waheed Ashraf, Sadaf Shabbir Kiani, Muhammad Nadir Khan, Asif Nadeem, Bakht Umar, Ayesha Sana, Javeria Kamran, Muhammad Yaseen   +7 more
doaj   +1 more source

The no‐reflow phenomenon in coronary arteries [PDF]

Journal of Thrombosis and Haemostasis, 2004
No reflow occurs when there is inadequate myocardial perfusion of a given segment of the coronary circulation without evidence of epicardial vessel obstruction. It is a rare but clinically significant condition associated with myocardial infarction and coronary interventions. Diagnosis is usually based on clinical signs of myocardial ischemia (symptoms
R V, Kelly, M G, Cohen, M S, Runge, G A, Stouffer   +3 more
openaire   +2 more sources

«No-reflow» phenomenon and risk factors associated with its development after primary percutaneous coronary interventions in patients with ST elevation myocardial infarction [PDF]

, 2018
The aim – to determine the incidence of the «no-reflow» phenomenon (NRP) after percutaneous coronary intervention (PCI) in patients with ST elevation myocardial infarction and to investigate clinical, anamnestic and angiographic risk factors associated ...
M.M. Doloh, V.І. Tseluyko, O.A. Leonenko   +2 more
core   +1 more source

Pharmacological correction of no-reflow phenomenon in myocardial infarction treatment

Бюллетень сибирской медицины, 2009
This article presents the research findings on the impact of carvedilol on the course of the necrosis myocardium focus and malone dialdegid concentration with patients, afflicted with acute myocardial infarction.
T. Yu. Mamonova, V. A. Markov, V. V. Udut   +2 more
doaj   +1 more source

Predicting the no-reflow phenomenon following successful percutaneous coronary intervention

, 2010
In the setting of acute myocardial infarction, early and adequate reopening of an infarct-related artery is not necessarily followed by a complete restoration of myocardial perfusion. This condition is usually defined as 'no-reflow'.
Liuzzo G, Paraggio L, Galiuto L, de Caterina AR, Crea F   +4 more
core   +3 more sources

The Relationship Between The Level Of Serum Uric Acid And No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention İn Patients With St Segment Elevated Myocardial Infarction [PDF]

Düzce Tıp Fakültesi Dergisi, 2010
No-reflow phenomenon is the absence of myocardial perfusion despite adequate dilatation ofthe infarct related coronary artery during percutaneous coronary intervention.
İsmail ERDEN, Emine Çakcak ERDEN, Serhat Bahadır SÖZEN, Osman Kayapınar, Sabri Onur ÇAĞLAR, Cengiz BAŞAR
doaj  

LncRNA MALAT1 functions as a biomarker of no-reflow phenomenon in ST-segment elevation myocardial infarction patients receiving primary percutaneous coronary intervention

Scientific Reports, 2022
MALAT1 was reported to sponge miR-30e, miR-126 and miR-155 in the pathogenesis of many diseases. Plasma miR-30e can indicate the risk of no-reflow during primary percutaneous coronary intervention (pPCI), while miR-126 can be used as a predictor of ...
Xiheng Yang, Rixin Dai, Zhong Qin, Ruping Cai, Yuli Xu, Qiang Su   +5 more
doaj   +1 more source

Impact of the Total Ischemia Time on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Anatolian Journal of Cardiology, 2022
Background: No-reflow phenomenon after primary percutaneous coronary intervention is a common condition affecting the outcomes; therefore, studying its predictive factors is helpful in identifying patients at high risk.
Mohamed Khalfallah, Amany Allaithy, Dina Abdelsalam   +2 more
doaj   +1 more source

Inflammation-Based C-Reactive Protein-to-Albumin Ratio for No-Reflow Prediction in STEMI

Biomedicines
Background: The C-reactive protein/albumin ratio (CAR) has increasingly attracted attention as a reliable predictive marker in patients with acute myocardial infarction (AMI).
Xhevdet Krasniqi, Altinë Spanca, Gresa Gojani, Josip Vincelj, Blerim Berisha, Aurora Bakalli   +5 more
doaj   +1 more source